Literature DB >> 6467262

Systemic compliance: does it play a role in the genesis of essential hypertension?

O S Randall, G C van den Bos, N Westerhof.   

Abstract

Arterial compliance is part of the load faced by the heart. Decreased compliance increases this load. We have studied the cardiovascular consequences of decreased systemic compliance in six closed chest anaesthetised dogs where ascending aortic flow transducers and left ventricular crystals had previously been implanted. A stiff tube was put into the abdominal aorta from the left flank and moved to the ascending aorta. Inflation of a cuff on the proximal end of the tube forced the heart to eject into a non-compliant outflow conduit. The distal end of the tube was connected to the distal aorta and, via a pump, to a carotid artery where mean pressure was kept above 80 mmHg. We measured systemic pressures (catheter-tip manometer), cardiac output (electromagnetic flowmeter) and either left ventricular end-diastolic pressure (fluid filled catheter, Statham P23Db) or left ventricular diameter (ultrasound transit time method). From these variables we calculated systemic compliance and input impedance. A 35% decrease in compliance caused a 12% increase in systolic, and a 12% decrease in diastolic pressure while mean pressure and cardiac output did not change significantly. With a decrease in compliance of 63% systolic pressure increased by 18%, while diastolic pressure decreased by 24%. Mean pressure did not change significantly but cardiac output fell by 21%. In both groups of altered compliance peripheral resistance rose slightly but this was not significant. Decreased compliance mainly caused changes in the low frequency range of the input impedance: moduli increased and phase angles became more negative.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1984        PMID: 6467262     DOI: 10.1093/cvr/18.8.455

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  21 in total

1.  The use of nitroprusside to characterize aortic pressure-diameter relationships.

Authors:  J J Ferguson; S Momomura; P Sahagian; M J Miller; R G McKay
Journal:  Tex Heart Inst J       Date:  1989

2.  Estimation of arterial compliance in aortic regurgitation: three methods evaluated in pigs.

Authors:  S A Slørdahl; H Piene; J E Solbakken; O Rossvoll; S O Samstad; B A Angelsen
Journal:  Med Biol Eng Comput       Date:  1990-07       Impact factor: 2.602

Review 3.  The arterial Windkessel.

Authors:  Nico Westerhof; Jan-Willem Lankhaar; Berend E Westerhof
Journal:  Med Biol Eng Comput       Date:  2008-06-10       Impact factor: 2.602

4.  Effect of interval training programme on pulse pressure in the management of hypertension: a randomized controlled trial.

Authors:  L Sikiru; G C Okoye
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

5.  Influence of arterial compliance on presence and extent of ischaemia during stress echocardiography.

Authors:  B A Haluska; K Matthys; R Fathi; E Rozis; S G Carlier; T H Marwick
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

6.  Panel A wrap-up: concepts, considerations, and challenges in managing hypertension in African-American patients.

Authors:  O S Randall
Journal:  J Natl Med Assoc       Date:  1995-08       Impact factor: 1.798

Review 7.  The therapeutic dilemma of hypertension in the elderly.

Authors:  S Julius
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 8.  Treatment of hypertension based on both systolic and diastolic pressure could influence the cost of therapy.

Authors:  M Safar
Journal:  Cardiovasc Drugs Ther       Date:  1989-12       Impact factor: 3.727

9.  Arterial hemodynamics in human hypertension.

Authors:  C T Ting; K P Brin; S J Lin; S P Wang; M S Chang; B N Chiang; F C Yin
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

Review 10.  Hypertension and concomitant diseases: a guide for evidence-based therapy.

Authors:  Tamrat M Retta; Otelio S Randall
Journal:  J Natl Med Assoc       Date:  2004-04       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.